Stocks Health care MRAI
OTC · Health careMarpai, Inc. (MRAI)
Marpai, Inc. brought in $16.6M of revenue over the twelve months to June 30, 2026, down 29.7% from a year earlier. It posted a net loss of $16.9M. At June 30, 2026 it held $138K in cash against $20.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Watch MRAI in 60 secondsWhat Marpai, Inc. does
Marpai, Inc. is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on OTC under the ticker MRAI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $18.1M | -$16.6M | -$0.95 | n/a |
| 2024 | $28.2M | -$22.1M | -$1.92 | n/a |
| 2023 | $37.2M | -$28.8M | -$4.14 | n/a |
| 2022 | $24.3M | -$26.5M | -$5.23 | -$35.6M |
| 2021 | $14.2M | -$16M | -$6.35 | -$11.1M |
| 2021 | n/a | -$3.9M | -$6.39 | -$2M |
Full financial statements: income, balance sheet and cash flow
Where MRAI ranks in Health care
Latest SEC filings
What Marpai, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Activist stake changed SCHEDULE 13D/A
- August 13, 2026Activist stake (5% or more) SCHEDULE 13D
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 11% to $4.2M versus the same quarter last year; diluted EPS -$0.18 versus -$0.28.
- July 31, 2026
- July 20, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 18% to $4.4M versus the same quarter last year; diluted EPS -$0.13 versus -$0.21.
- May 1, 2026
- March 25, 2026Annual report 10-K · period to December 31, 2025Revenue fell 36% to $18.1M versus the prior year; diluted EPS -$0.95 versus -$1.92.
- March 11, 2026
- February 27, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Marpai, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 2, 2026 | Johnson Steve AndrewChief Financial Officer | Bought | 1,100 | $682 |
| May 29, 2026 | DiClaudio ColleenDirector | Received as pay | 125,000 | - |
| May 29, 2026 | Lamendola DamienChief Executive Officer, Director, 10% owner | Received as pay | 300,000 | - |
| May 29, 2026 | Calabrese Jennifer RosarioDirector | Received as pay | 100,000 | - |
| May 29, 2026 | Pons Robert MDirector | Received as pay | 100,000 | - |
| May 29, 2026 | Shiv SagivDirector | Received as pay | 125,000 | - |
| May 29, 2026 | Johnson Steve AndrewChief Financial Officer | Received as pay | 125,000 | - |
| May 29, 2026 | Eitan YaronDirector | Received as pay | 175,000 | - |
| May 20, 2026 | Eitan YaronDirector | Bought | 10,000 | $2.7K |
| February 19, 2026 | Shiv SagivDirector | Received as pay | 100,000 | - |
| December 8, 2025 | Calabrese Jennifer RosarioDirector | Other change | 50,000 | - |
| December 8, 2025 | Pons Robert MDirector | Other change | 50,000 | - |
| December 8, 2025 | Shiv SagivDirector | Other change | 50,000 | - |
| December 8, 2025 | Eitan YaronDirector | Other change | 50,000 | - |
Who owns MRAI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Damien Lamendola13D, may seek influence with 2 related filers | 40.51% | October 22, 2025 |
| Mitchell Family Trust II13D, may seek influence with 2 related filers | 10.1% | August 13, 2026 |
Largest institutional holders
Insiders
7 insiders reported holding 5,488,632 shares in total, about $18.6M at the last price.
| Holder | Shares |
|---|---|
| Lamendola DamienChief Executive Officer, Director, 10% owner | 1,650,000 |
| Eitan YaronDirector | 1,224,073 |
| Johnson Steve AndrewChief Financial Officer | 1,024,192 |
| Shiv SagivDirector | 613,667 |
| Pons Robert MDirector | 484,200 |
| DiClaudio ColleenDirector | 267,500 |
| Calabrese Jennifer RosarioDirector | 225,000 |
Questions about MRAI
What does Marpai, Inc. do?
Marpai, Inc. is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on OTC under the ticker MRAI.
Is Marpai, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $16.9M on revenue of $16.6M.
How much revenue does Marpai, Inc. make?
Over the twelve months to June 30, 2026 Marpai, Inc. reported revenue of $16.6M. That is 29.7% less than a year earlier.
When did Marpai, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.
Similar companies
Compare MRAI with
Follow MRAI
Get an email when Marpai, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MRAI: get an email when it filesWhere the numbers come from
Financial figures are the values Marpai, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.